Literature DB >> 9490664

Malignancies after hematopoietic stem cell transplantation: many questions, some answers.

H J Deeg1, G Socie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490664

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  27 in total

1.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation.

Authors:  Christopher J Fraser; Betsy A Hirsch; Vanessa Dayton; Michael H Creer; Joseph P Neglia; John E Wagner; K Scott Baker
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

3.  Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.

Authors:  Debra L Friedman; Alicia Rovo; Wendy Leisenring; Anna Locasciulli; Mary E D Flowers; Andre Tichelli; Jean E Sanders; H Joachim Deeg; Gerard Socie
Journal:  Blood       Date:  2007-10-02       Impact factor: 22.113

4.  [Cognitive deficits following hematopoietic stem cell transplantation in childhood].

Authors:  Martin G Sauer
Journal:  Strahlenther Onkol       Date:  2015-05       Impact factor: 3.621

5.  Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature.

Authors:  Thomas H Beckham; Jonathan Leeman; Chiaojung Jillian Tsai; Nadeem Riaz; Eric Sherman; Bhuvanesh Singh; Nancy Lee; Sean McBride; Daniel S Higginson
Journal:  Head Neck       Date:  2019-01-11       Impact factor: 3.147

6.  Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era.

Authors:  Sarah F Keller; Jennifer L Kelly; Elizabeth Sensenig; Jennifer Andreozzi; Jamie Oliva; Lynn Rich; Louis Constine; Michael Becker; Gordon Phillips; Jane Liesveld; Richard I Fisher; Steven H Bernstein; Jonathan W Friedberg
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-24       Impact factor: 5.742

7.  Secondary chronic myelogenous leukemia after autologous peripheral blood stem cell transplantation for lymphoma.

Authors:  H H Hsiao; T C Liu; C S Chang; Y C Sue; T P Chen; S F Lin
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 8.  EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.

Authors:  L Rasche; M Kapp; H Einsele; S Mielke
Journal:  Bone Marrow Transplant       Date:  2013-07-08       Impact factor: 5.483

9.  Excellent response to gemcitabine in a massively pre-treated woman with extensive cutaneous involvement after recurrence of breast cancer.

Authors:  J Arends; C Unger
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

10.  Immune surveillance and lymphoid malignancy in immunocompromised host.

Authors:  Patrick L Stevens; Nishitha M Reddy
Journal:  Am J Blood Res       Date:  2013-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.